Lenperone

Lenperone
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

File:Lenperone.svg

Lenperone.svg

Lenperone is a typical antipsychotic medication primarily used in the treatment of schizophrenia and other psychotic disorders. It belongs to the class of drugs known as butyrophenones, which also includes the well-known antipsychotic haloperidol.

Pharmacology[edit]

Lenperone works by blocking dopamine receptors in the brain, particularly the D2 receptors. This action helps to reduce the symptoms of psychosis, such as hallucinations and delusions. The drug may also have some effects on other neurotransmitter systems, including serotonin and norepinephrine.

Indications[edit]

Lenperone is indicated for the treatment of:

Side Effects[edit]

Common side effects of Lenperone include:

Sedation
Extrapyramidal symptoms (such as tremors, rigidity, and bradykinesia)
Weight gain
Dry mouth
Constipation

Serious side effects may include:

Contraindications[edit]

Lenperone is contraindicated in individuals with:

Known hypersensitivity to Lenperone or other butyrophenones
Severe central nervous system depression
Parkinson's disease

Dosage[edit]

The dosage of Lenperone varies depending on the condition being treated and the patient's response to the medication. It is typically administered orally, and the dosage is gradually adjusted to achieve the desired therapeutic effect while minimizing side effects.

History[edit]

Lenperone was developed in the mid-20th century as part of the butyrophenone class of antipsychotics. It was introduced as an alternative to other antipsychotic medications with the aim of providing effective treatment for psychotic disorders with a different side effect profile.

References[edit]

External Links[edit]

This medical article is a stub. You can help WikiMD by expanding the page.